Checkpoint Therapeutics to Participate in the B. Riley Securities 4th Annual Oncology Conference

January 11, 2024

https://www.globenewswire.com/news-release/2024/01/11/2807906/36989/en/Checkpoint-Therapeutics-to-Participate-in-the-B-Riley-Securities-4th-Annual-Oncology-Conference.html

WALTHAM, Mass., Jan. 11, 2024 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq:CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that James Oliviero, President and Chief Executive Officer, will participate in a fireside chat at the B. Riley Securities 4th Annual Oncology Conference, taking place on Thursday, January 18, 2024, at 4:00 p.m. EST.

Read more at globenewswire.com

Related news for (CKPT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.